Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

Keeping Current CME

English - April 04, 2024 18:48 - 28 minutes - 40.9 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Insights From the Experts on Prescription Digital Therapeutics in Psychiatry

Next Episode: Care Pathways for Diagnostic Excellence: Understanding Provider Roles and Responsibilities

Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?

Credit available for this activity expires: 3/29/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu